MDxHealth SA
F:O6C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MDxHealth SA
F:O6C
|
BE |
|
Murphy Oil Corp
NYSE:MUR
|
US |
|
Dexus
F:0DPS
|
AU |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FMEA
|
DE |
|
A
|
Avex Inc
F:AX8
|
JP |
|
F
|
Farmland Partners Inc
F:0FA
|
US |
|
E
|
EQT Corp
XMUN:EQ6
|
US |
|
M
|
Melrose Industries PLC
OTC:MLSPF
|
UK |
|
M
|
Microchip Technology Inc
F:MCP
|
US |
|
N
|
Netscout Systems Inc
F:NSZ
|
US |
|
A
|
AXA SA
F:AXAA
|
FR |
|
Fuelcell Energy Inc
NASDAQ:FCEL
|
US |
|
P
|
PepsiCo Inc
DUS:PEP
|
US |
|
F
|
Freeport-McMoRan Inc
XMUN:FPMB
|
US |
|
R
|
Reliance Steel & Aluminum Co
F:RS6
|
US |
|
T
|
Tapestry Inc
XMUN:COY
|
US |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
US |
|
P
|
Plan B Media PCL
SET:PLANB
|
TH |
Wall St Price Targets
O6C Price Targets Summary
MDxHealth SA
According to Wall Street analysts, the average 1-year price target for O6C is 27.338 EUR with a low forecast of 21.949 EUR and a high forecast of 34.227 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is O6C's stock price target?
Price Target
27.338
EUR
According to Wall Street analysts, the average 1-year price target for O6C is 27.338 EUR with a low forecast of 21.949 EUR and a high forecast of 34.227 EUR.
What is the Revenue forecast for MDxHealth SA?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 4 years is 22%.